Standard Contracts
First Amendment to Worldwide Exclusive License AgreementWorldwide Exclusive License Agreement • June 7th, 2022 • Aeris Biotechnologies, Inc. • Pharmaceutical preparations
Contract Type FiledJune 7th, 2022 Company IndustryTHIS FIRST AMENDMENT TO WORLDWIDE EXCLUSIVE LICENSE AGREEMENT (“Amendment”) is executed and effective this 22nd day of May, 2022 by and between Aeris Biotechnologies, Inc. (“Aeris”) and Evolution Biotechnologies, Limited (“Evolution”).